Perilesional treatment of metastatic melanoma with interferon-β

T. Fujimura; R. Okuyama; T. Ohtani; Y. Ito; T. Haga; A. Hashimoto; S. Aiba

doi:10.1111/j.1365-2230.2009.03207.x

Perilesional treatment of metastatic melanoma with interferon-β

T. Fujimura, R. Okuyama, T. Ohtani, Y. Ito, T. Haga, A. Hashimoto, S. Aiba

Sense Organs and Rehabilitation Medicine

Research output: Contribution to journal › Article › peer-review

29 Citations (Scopus)

Abstract

Previous trials with various treatments have not shown satisfactory therapeutic results for cutaneous metastasis of malignant melanoma (MM). We report three patients who were treated with peritumoral injection of interferon (IFN)-β for multiple skin metastases of MM. The metastatic tumours were infiltrated by significant numbers of CD8+ TIA+ cytotoxic lymphocytes, and the numbers of CD4+ cells and human leucocyte antigen-DR+ cells increased after IFN-β injection. These results suggest that the peritumoral administration of IFN-β enhanced the antitumour immune response against the MM, suggesting that it is a promising supportive treatment for skin metastasis of MM.

Original language	English
Pages (from-to)	793-799
Number of pages	7
Journal	Clinical and Experimental Dermatology
Volume	34
Issue number	7
DOIs	https://doi.org/10.1111/j.1365-2230.2009.03207.x
Publication status	Published - 2009 Oct

ASJC Scopus subject areas

Dermatology

Access to Document

10.1111/j.1365-2230.2009.03207.x

Cite this

@article{ef32660874f943c69c275868d1ee278d,

title = "Perilesional treatment of metastatic melanoma with interferon-β",

abstract = "Previous trials with various treatments have not shown satisfactory therapeutic results for cutaneous metastasis of malignant melanoma (MM). We report three patients who were treated with peritumoral injection of interferon (IFN)-β for multiple skin metastases of MM. The metastatic tumours were infiltrated by significant numbers of CD8+ TIA+ cytotoxic lymphocytes, and the numbers of CD4+ cells and human leucocyte antigen-DR+ cells increased after IFN-β injection. These results suggest that the peritumoral administration of IFN-β enhanced the antitumour immune response against the MM, suggesting that it is a promising supportive treatment for skin metastasis of MM.",

author = "T. Fujimura and R. Okuyama and T. Ohtani and Y. Ito and T. Haga and A. Hashimoto and S. Aiba",

year = "2009",

month = oct,

doi = "10.1111/j.1365-2230.2009.03207.x",

language = "English",

volume = "34",

pages = "793--799",

journal = "Clinical and Experimental Dermatology",

issn = "0307-6938",

publisher = "Wiley-Blackwell",

number = "7",

}

TY - JOUR

T1 - Perilesional treatment of metastatic melanoma with interferon-β

AU - Fujimura, T.

AU - Okuyama, R.

AU - Ohtani, T.

AU - Ito, Y.

AU - Haga, T.

AU - Hashimoto, A.

AU - Aiba, S.

PY - 2009/10

Y1 - 2009/10

N2 - Previous trials with various treatments have not shown satisfactory therapeutic results for cutaneous metastasis of malignant melanoma (MM). We report three patients who were treated with peritumoral injection of interferon (IFN)-β for multiple skin metastases of MM. The metastatic tumours were infiltrated by significant numbers of CD8+ TIA+ cytotoxic lymphocytes, and the numbers of CD4+ cells and human leucocyte antigen-DR+ cells increased after IFN-β injection. These results suggest that the peritumoral administration of IFN-β enhanced the antitumour immune response against the MM, suggesting that it is a promising supportive treatment for skin metastasis of MM.

AB - Previous trials with various treatments have not shown satisfactory therapeutic results for cutaneous metastasis of malignant melanoma (MM). We report three patients who were treated with peritumoral injection of interferon (IFN)-β for multiple skin metastases of MM. The metastatic tumours were infiltrated by significant numbers of CD8+ TIA+ cytotoxic lymphocytes, and the numbers of CD4+ cells and human leucocyte antigen-DR+ cells increased after IFN-β injection. These results suggest that the peritumoral administration of IFN-β enhanced the antitumour immune response against the MM, suggesting that it is a promising supportive treatment for skin metastasis of MM.

UR - http://www.scopus.com/inward/record.url?scp=70349507952&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349507952&partnerID=8YFLogxK

U2 - 10.1111/j.1365-2230.2009.03207.x

DO - 10.1111/j.1365-2230.2009.03207.x

M3 - Article

C2 - 19438554

AN - SCOPUS:70349507952

VL - 34

SP - 793

EP - 799

JO - Clinical and Experimental Dermatology

JF - Clinical and Experimental Dermatology

SN - 0307-6938

IS - 7

ER -

Perilesional treatment of metastatic melanoma with interferon-β

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this